1. Home
  2. FCEL vs XNCR Comparison

FCEL vs XNCR Comparison

Compare FCEL & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

N/A

Current Price

$22.08

Market Cap

1.2B

Sector

Energy

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$23.02

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCEL
XNCR
Founded
1969
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
FCEL
XNCR
Price
$22.08
$23.02
Analyst Decision
Hold
Buy
Analyst Count
4
9
Target Price
$8.31
$22.33
AVG Volume (30 Days)
8.3M
1.1M
Earning Date
06-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
5.24
65.36
EPS
N/A
N/A
Revenue
$89,437,000.00
$125,576,000.00
Revenue This Year
$4.77
N/A
Revenue Next Year
$42.46
$4.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.65
52 Week Low
$3.78
$7.13
52 Week High
$37.88
$23.45

Technical Indicators

Market Signals
Indicator
FCEL
XNCR
Relative Strength Index (RSI) 50.94 73.35
Support Level $17.33 $11.05
Resistance Level $26.16 N/A
Average True Range (ATR) 2.54 1.24
MACD 0.12 0.14
Stochastic Oscillator 47.61 95.91

Price Performance

Historical Comparison
FCEL
XNCR

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: